Introduction
============

Humans play host to 500--1000 different species of bacteria in the intestine and 100 times more bacterial cells than eukaryotic cells (Whitman et al., [@B109]). Increased appreciation for the crucial role that the intestinal microbiota plays in host health and immunity is continually surfacing. While mammalian hosts provide a nutrient rich niche for these bacteria, the bacteria provide the host with much more including: aid in digestion, protection against pathogenic enteric pathogens, and development of the immune system (Hooper and Gordon, [@B33]; Macpherson and Harris, [@B58]; Sekirov et al., [@B82]; Sekirov and Finlay, [@B81]). Indeed, a skewed microbiota balance can affect health in numerous ways and can lead to conditions that promote diseases such as obesity, diabetes, inflammatory bowel disorders, and multiple sclerosis (Round and Mazmanian, [@B73]; Ochoa-Reparaz et al., [@B66]). Additionally, a skewed microbiota can leave a host susceptible to infection (Manichanh et al., [@B60]; Turnbaugh et al., [@B100], [@B98]; Frank et al., [@B22]; Garrett et al., [@B26]; Peterson et al., [@B69]; Wen et al., [@B108]). The complexity of the mammalian intestinal microbiota has long been appreciated; however, our knowledge of this area has greatly expanded in recent years as more advanced sequencing methods have become available. Due to the harsh conditions of the intestine, many of the organisms which dwell there are fastidious and cannot be cultured *in vitro*. Modern sequencing techniques have enabled us to begin cataloging in detail the microbial life that exists within the intestine whether or not it can be cultured *ex vivo* (Turnbaugh et al., [@B99]). The importance of commensal bacteria in host development and health is most clearly demonstrated by germ-free mice, raised in the absence of any bacteria. These mice exhibit numerous developmental defects, which can be compensated for by microbial colonization (Macpherson and Harris, [@B58]).

Developmental problems and defects faced by germ-free mice are, in part, centered around immune system development and function (Smith et al., [@B86]). While not an exhaustive list, some of the immunological defects seen in germ-free mice include immature lymphoid follicles, an enlarged cecum, reduced plasma cells and reduced production of mucosal immunolobulin A (IgA), anti-microbial peptides, and adenosine tri-phosphate (ATP). The number of CD8+ intestinal epithelial cells (IELs) and αβ T-cell receptor (TCR) IELs is reduced as well as Thy1 expression and cytolytic activity. IEL expression of major histocompatibility complex (MHC) II, Toll-like receptor (TLR) 9, and interleukin (IL) 25 is also reduced. CD4+ T-cells in the lamina propria (LP), Foxp3+ regulatory cells in the colonic LP, and CD4+CD25+ T-cells in the mesenteric lymph nodes (MLNs) are reduced. Immune structures in germ-free animals are also compromised. The Peyer's patches are small compared to conventional animals, and the spleens and MLNs have depletion of lymphocyte zones (Lefrancois and Goodman, [@B55]; Rothkotter and Pabst, [@B72]; Shroff et al., [@B84]; Umesaki et al., [@B105]; Smith et al., [@B86]; Round and Mazmanian, [@B73]). Finally, germ-free mice have increased susceptibility to infection from enteric pathogens. It has been shown that they have less resistance than conventional mice to infection with: *Shigella flexneri*, *Listeria monocytogenes, Clostridium difficile*, and *Salmonella enterica* (Sprinz et al., [@B90]; Zachar and Savage, [@B112]; Nardi et al., [@B64]). When germ-free mice are colonized with as little as one commensal bacterial species, the susceptibility to infection is reduced. This feat is not accomplished by every intestinal commensal organism, however, indicating that colonization resistance (CR) ability is specific (Maier and Hentges, [@B59]; Round and Mazmanian, [@B73]; Ivanov and Littman, [@B40]).

Given the number of bacterial species residing in the intestine, it is hard to imagine teasing out specific contributions by individual species. However, mono-colonization of germ-free mice has allowed exactly this and we have gained important knowledge by examining which components of the faulty germ-free mouse immune system can be re-constituted with the addition of one bacterial species. This review highlights several groups of bacterial species that have been shown to play an important role in immune development and homeostasis and were characterized in this manner. While not an exhaustive description of enteric bacteria that affect host immune systems, the groups we have picked form a representative sample of species that show varied impacts on their hosts. Each of these groups has been historically well studied; however, recent advances make them particularly relevant.

Bacteroides Fragilis
====================

Although members of the *Bacteroidales* order are the most prominent gram negative bacteria in the intestine, the colonic bacteria *Bacteroides fragilis* make up only one percent of intestinal microbiota. While not numerically dominant amongst the *Bacteroidetes* in the intestine, this species of *Bacteroides* has been shown to have important effects on host health, both beneficial and detrimental (Polk and Kasper, [@B70]; Troy and Kasper, [@B97]). Normally symbiotic when contained within the intestine, in the event of bowel perforation, *B. fragilis* becomes pathogenic, inducing abscess formation throughout the peritoneal cavity (Polk and Kasper, [@B70]). *B. fragilis* is the most common clinically isolated anaerobic bacterial species, but in recent years, has become more well-known for the extent of positive effects it exerts on the immune system (Polk and Kasper, [@B70]; Mazmanian et al., [@B61], [@B62]; Lassmann et al., [@B53]). *B. fragilis* and other *Bacteroides* have the genetic capability to produce multiple capsular polysaccharides, with *B. fragilis* producing eight. In *B. fragilis* these polysaccharides are important for commensal colonization of the intestine (Krinos et al., [@B52]; Coyne et al., [@B14]; Liu et al., [@B56]). At least two of these polysaccharides, polysaccharide A (PSA) and polysaccharide B (PSB) contain both positive and negative charges, making them zwitterionic (Tzianabos et al., [@B103]). Contrary to traditional characterization of carbohydrates as T-cell independent (Gonzalez-Fernandez et al., [@B27]), PSA and other zwitterionic carbohydrates evoke both CD4+ T-cell dependent and T-cell independent immune responses (Tzianabos et al., [@B102]; Cobb et al., [@B11]). Many characterized zwitterionic carbohydrates from bacteria have been shown to have immunomodulatory properties (Tzianabos et al., [@B103], [@B102], [@B104]; Cobb et al., [@B11]); however, PSA might be the most well-characterized microbial factor involved in commensalism. When germ-free mice are colonized with *B. fragilis*, many of the defects seen in these mice are corrected almost to the level of conventionally colonized mice (Mazmanian et al., [@B61]). Colonization of germ-free mice with *B. fragilis* promotes expansion of CD4+ T-cells, corrects depletion of splenic lymphocytic zones, and corrects Th1/Th2 imbalances by reduced IL-4 production and increased interferon (IFN)-γ production. Importantly, these rescue effects have been narrowed down to the activity of zwitterionic PSA. When *B. fragilis* defective in production of PSA is used to colonize germ-free mice, no correction of Th1/Th2 imbalance is seen. This was one of the first instances that showed correction of germ-free immunological defects by not just a commensal organism, but a specific surface molecule or symbiosis factor (Mazmanian et al., [@B61]). *B. fragilis's* immunomodulatory capabilities have been shown to directly play a role in health and disease. Numerous studies have shown that an imbalance of microbiota can lead to intestinal inflammation due to lack of mucosal immune tolerance (Frank et al., [@B22]; Round and Mazmanian, [@B73]; Ivanov and Littman, [@B41]). *B. fragilis* has been shown to be protective against both immune (CD4+CD45Rb transfer with *Helicobacter hepaticus* inoculation) and chemically (trinitrobenzene sulfonic acid, TNBS) induced colitis (Mazmanian et al., [@B62]). In addition, purified PSA itself is protective against chemically induced colitis. This protection is dependent on CD4+ production of IL-10, induced by PSA. In animals defective for IL-10 production, no protective effect is seen by *B. fragilis* (Mazmanian et al., [@B62]). *B. fragilis* has subsequently been shown to alleviate chemically induced colitis in mice post colitis induction, showing that it can have both a preventative and therapeutic role. IL-10 production induced by *B. fragilis* results from increased numbers of Foxp3+ T-regulatory cells and mono-colonization of mice with *B. fragilis* has shown that these bacteria alone are capable of mediating the development of Foxp3+ T-regulatory cells from CD4+ T-cells (Round and Mazmanian, [@B74]). The anti-inflammatory effects of *B. fragilis* are not limited to a role in mouse models of models of colitis, but also additional models of inflammatory disease. For example, it was recently shown that *B. fragilis* is protective against an experimental autoimmune encephomyelitis (EAE), a mouse model mimicking human multiple sclerosis (Ochoa-Reparaz et al., [@B66]). In an initial study, Ochoa-Reparaz et al., showed that purified *B. fragilis* PSA given to mice orally could protect against EAE. The administration of PSA to these mice enhanced a population of dendritic cells which express CD103 and these cells were seen accumulating in the cervical lymph nodes. Similar to the proposed mechanism for PSA's protection against colitis, in IL-10 deficient mice, PSA offered no protection (Ochoa-Reparaz et al., [@B65]). In an exciting follow-up study, the same group showed that oral colonization of mice with the entire organism, *B. fragilis,* could also protect against EAE and when a PSA deficient strain of *B. fragilis* was used, no protection was seen. Similar to purified PSA, the addition of *B. fragilis* to these mice stimulated the numbers of Foxp3+ T-regulatory cells accumulating in the cervical lymph nodes (Ochoa-Reparaz et al., [@B65],[@B66]). These studies are particularly ground-breaking since they show one of the first examples of systemic effects of *B. fragilis's* immunomodulatory capabilities. *B. fragilis* and PSA's anti-inflammatory properties are currently being tested in other models of inflammation to determine how universal their effects are.

Segmented Filamentous Bacteria
==============================

Segmented filamentous bacteria (SFB) or *Candidatus* Arthromitus (Snel et al., [@B87]) were originally observed and morphologically characterized over three decades ago in the small intestine of rats, mice, and chickens. These segmented organisms uniquely attach to the apical epithelium of primarily the small intestine through an attachment point in which the host cell epithelium and apical cytoplasm is modified (Hampton and Rosario, [@B29]; Savage, [@B78]; Fuller and Turvey, [@B23]; Davis and Savage, [@B15]). The biology of these organisms is intriguing as they appear in numerous vertebrates after birth and disappear shortly after adulthood (Davis and Savage, [@B15]). Early reports indicate many influences over the colonization of SFB within a host organism including age, sex, and immune status (Davis and Savage, [@B15]; Jiang et al., [@B43]). The timing of the appearance of these organisms in their vegetative state has led to numerous studies as well as speculation about the environmental signal that induces sporulation or overall disappearance of SFB from their host. It is possible that this could be related to the establishment of microbial colonization in young vertebrates or possibly it is related to nutritional changes once mammals are weaned from their mothers. Microscopically, SFB have been observed in numerous laboratory and non-laboratory vertebrates, including chickens, dogs, cats, pigs, fowl, macaque, and humans (Klaasen et al., [@B45]); however, they have also been shown to be extremely species specific. Tannock et al. ([@B96]) showed that when ileal homogenates containing SFB from mice were given to germ-free rats, the SFB failed to attach to the epithelium. Likewise, when ileal homogenates containing SFB from rats were given to germ-free mice, the SFB also failed to adhere to the epithelium, whereas when source SFB were given to the same species, they were able to adhere to the epithelium (Tannock et al., [@B96]). This indicates a co-evolutionary relationship between SFB and their hosts. Although SFB were visualized by light microscopy to be part of the human microbiota, definitive genetic identification of these microbes in humans has not been reported (Klaasen et al., [@B45]). Many of the aforementioned characteristics of SFB led researchers to believe they had an important role in the immunology of their hosts; however, the un-culturability of SFB has made many studies of this organism's unique features impossible. A break-through came with the ability to mono-colonize mice with SFB. Several groups were able to take fecal homogenates and limit them to only spore-forming bacteria using chloroform and ethanol washes (Klaasen et al., [@B47]). These mixes of SFB and some *Clostridium* species could be diluted to only contain SFB and were illeo-inoculated into mice establishing a mono-colonized species (Klaasen et al., [@B46]). The study of mice mono-colonized with SFB in combination with high powered sequencing methods has allowed many groups to observe the profound effects that SFB have on their host's immunity (Klaasen et al., [@B46]; Umesaki et al., [@B105]; Ivanov et al., [@B39], [@B38]; Gaboriau-Routhiau et al., [@B24]).

Mono-colonization of mice with SFB leads to many immunological changes to germ-free mice particularly within the small intestine. In the small intestine, there is an induction of MHCII molecules on IECs as well as fucosylation of GM1 glyco-lipids (Umesaki et al., [@B105]). Significant changes are also seen on IELs such as an expansion of IELs bearing both αβ and γδ TCRs, increased CD8+ T-cells, increased cytolytic activity, and increased Thy1 expression. Crypt cell proliferation is induced as well as production of columnar cells. Upon mono-colonization, germinal center reactions in the Peyer's patches are stimulated and CD4+ and CD45RB^low^ T-cells increase until they reach levels of conventional mice (Umesaki et al., [@B105]; Talham et al., [@B95]). IgA is also produced in significant amounts after SFB colonization of germ-free mice (Umesaki et al., [@B105]; Suzuki et al., [@B94]). While these changes are substantial, the levels of αβ TCRS do not fully come up to conventional levels nor are many of the morphological characteristics of germ-free mice such as an enlarged cecum normalized (Umesaki et al., [@B105]; Talham et al., [@B95]). Interestingly, in mice deficient in IgA, a prominent and persistent expansion of SFB is seen that returns to normal when the mice are compensated with IgA (Suzuki et al., [@B94]). IgA is seen as a major mechanism for maintaining intestinal homeostasis among commensal organisms (Duerkop et al., [@B18]), and its absence in these mice is compensated for by large amounts of IgM and normal expression of defensins and angiogenins (Suzuki et al., [@B94]). This reaffirms the paradigm in which an IgA feedback loop is a method of keeping commensal organisms near the epithelial surface in check (Hooper, [@B32]).

Most recently, several studies have pinpointed dramatic effects of SFB colonization based on their presence in some host species and not in others. A major indication of SFB's role in the induction of pro-inflammatory factors came with the report that mice from differing sources (Taconic Farms versus Jackson Laboratory) had differing levels of IL-17 producing cells and animals that had decreased Th17 cells had increased Foxp3+ regulatory cells (Ivanov et al., [@B39]). In a subsequent report, the authors were able to show, using 16S rRNA phylochip analysis, that SFB which were present in mice from some sources and not others accounted for the difference seen in Th17 cells. When the authors mono-colonized germ-free mice with SFB, they saw induction of Th17 cells that produce IL-17 and IL-22 in the lamina propria as well as up-regulation of genes associated with inflammation and anti-microbial defenses (Ivanov et al., [@B38]). In a similar deductive study, Gaboriau-Routhiau et al. noticed that they were able to conventionalize the transcriptome of germ-free mice with a murine microbiota, but not with a human fecal microbiota or cultured murine microbiota. This led them to believe an un-culturable organism must be the missing link to reconstituting conventional level gene responses in their germ-free mice. They deduced that SFB may be the missing link and upon mono-colonizing mice with these organisms, they saw expression of many mucosal genes equal to those of conventional mice including: RegIIIγ, IFNγ, IL-1β, IL-10, IL-17, inducible nitric oxide synthase (iNOS), and IL-12p40. They also saw local induction of IFNγ, IL-10, and IL-17. SFB increased production of IFNγ by CD4+ T-cells, IL-17 production by CD4+ T-cells and increased the total number of CD4+CD25+Foxp3+ T-regulatory cells in the lamina propria of the small intestine and colon (Gaboriau-Routhiau et al., [@B24]). This induction of both pro-inflammatory and anti-inflammatory factors is extremely interesting; however, in general, SFB have been more frequently associated with pro-inflammatory Th17 cells (Ivanov et al., [@B39], [@B38]; Wu et al., [@B110]). Importantly, while SFB were initially suspected to be a sole factor needed to conventionalize mice, none of these factors were increased to conventional levels, indicating that SFB works in concert with other commensal organisms (Gaboriau-Routhiau et al., [@B24]). Due to their stimulation of the immune system and immediate proximity to the host epithelium, many groups have hypothesized that SFB are involved in CR to host enteric pathogens. Several studies have already shown that in the presence of SFB, hosts are immune to organisms they might otherwise by susceptible to. For example, Heczko et al. ([@B30]) showed that rabbits colonized with SFB were less likely to be infected by rabbit enteropathogenic *Escherichia coli* (REPEC) and conversely, all rabbits who did not have SFB were colonized by REPEC. SFB has also been shown to have protective effects against *Salmonella enteritidis* in rats and *Citrobacter rodentium* in mice (Garland et al., [@B25]; Ivanov et al., [@B38]). The culmination of these studies and the observation that SFB are present at a young age strongly supports a role for SFB in CR, possibly selective, during the establishment of a host's intestinal microbiota.

It is well-known that the composition of the microbiota can have strong impacts on health and any imbalance can cause either susceptibility to infection or on the other side can lead to auto-inflammatory conditions. Although SFB have been designated as commensal organisms due to their generally non-pathogenic characteristics, it is possible that this classification may be pre-emptive as we learn more about the effects they exert on their hosts. Given SFB's strong pro-inflammatory capabilities, when not reined in by other regulatory factors, their effects could lead to diseased states. For example, recently it was shown that in a mouse model of autoimmune arthritis, for germ-free mice, arthritis is attenuated. Arthritis is quickly re-induced; however, with the addition of solely SFB (Wu et al., [@B110]). Similar phenomenon have been observed with SFB in EAE (Lee et al., [@B54]). Alternatively, SFB may exhibit pathogenic qualities in the presence of other bacteria. Work by Stepankova et al. indicates that SFB may require additional microbiota to exert its pro-inflammatory effects. This group showed that SFB could trigger chronic inflammation in SCID mice, which received CD45RB^high^ CD4+ T-cells. However, colitis was only triggered in germ-free SCID mice which received a cocktail of specific pathogen free (SPF) microbiota as well as SFB and not in the mice which received either SPF microbiota or SFB alone (Stepankova et al., [@B92]).

No studies thus far have looked at the long-term effects of mono-colonization of mice with SFB. We are just uncovering the surface in characterization of these organisms and their mechanisms. While they have been identified in humans through light microscopy (Klaasen et al., [@B45]), they have not been identified in humans using 16S rRNA sequencing. Understanding the true niche of this organism will help elucidate their role in host biology. Current work is underway to sequence the genome of these species from fecal DNA isolation. In addition, numerous efforts to culture this organism *in vitro* are underway in multiple labs. Armed with the genome sequence and a way to grow these organisms to high numbers in culture, there is potential to understand the molecular mechanisms behind the fascinating SFB interaction with mammalian epithelial cells and the mechanisms responsible for their effects.

Clostridium
===========

While SFB, located primarily in the small intestine of their hosts, induce effector T-cell function and pro-inflammatory conditions, a recent report shows that members of the genus *Clostridium*, most commonly located in the large intestine, do the exact opposite (Atarashi et al., [@B3]). This is may indicate that the commensal microbiota of the small and large intestine have compartmentalized effects on the resident T-cells. The effect of mixed *Clostridium* species on germ-free mice has been examined previously. In earlier, less controlled studies, the effect of colonizing germ-free mice with chloroform treated or, *Clostridium* rich feces from conventional mice was examined. Under these conditions, normalization of the enlarged germ-free cecum was seen and the mix of 46 *Clostridium* species was defined (Itoh and Mitsuoka, [@B35], [@B36]). These studies were some of the original work to show that *Clostridium* species alone can have a big impact on the intestinal status of a mouse and were part of the initial efforts to tease apart the roles of individual genuses in the intestine. More recent studies build upon those initial efforts by examining specific parameters induced by this defined mix of *Clostridium* species. In the recent study by Atarashi et al., a combination of 46 spore-forming *Clostridium* species mainly composed of clusters IV (*leptum)* and XIVa (*coccoides)* induced a strong anti-inflammatory response in the intestine through expansion of Foxp3+ regulatory T-cells. This effect was partially mediated by the release of TGF-β from IELs. The group showed that pattern recognition receptors such as *Myd88, Rip2*, and *Card9* were not involved. A similar regulatory T-cell accumulation was seen when the *Clostridium* mix was enhanced in normal mice with a healthy immune system and these mice were also more resistant to animal models of inflammation (Atarashi et al., [@B3]). This response invites the use of *Clostridium* as an anti-inflammatory probiotic. In future studies, it will be interesting to see how individual species of *Clostridium* have an effect on mucosal immunology especially considering the opposite effect exerted by very closely related SFB. Compartmentalized effects of *Clostridium* species and SFB species have been illustrated by the mono-colonization of germ-free mice with SFB or the aforementioned 46 species of *Clostridium* or dual colonized with both. In the SFB mice, αβ IELs and MHC II were increased only in the small intestine while in the *Clostridium* mice, CD8+ T-cells and αβ IELs were increased only in the large intestine. In the co-colonized mice, the mice more closely resembled conventional mice indicating a distinct balance and localization of the effects of each group of species (Umesaki et al., [@B106]).

Lactobacillus and Bifidobacterium
=================================

The beneficial health effects of the endogenous intestinal bacterial genera *Lactobacillus* and *Bifidobacterium* are reflected through their frequent use as probiotics. Species within these bacterial genera have anti-inflammatory properties as well as many other health benefits for hosts such as a contribution toward CR against pathogens, and aid in improved digestion, nutrient adsorption, and increased availability of nutrients in the intestine (Sanchez et al., [@B77]; Turpin et al., [@B101]). The genomes of *Bifidobacterium* species reflect a large propensity for carbohydrate uptake and metabolism as well as the presence of many enzymes for the break-down of complex carbohydrates. These traits are thought to give *Bifidobacterium* species a competitive advantage within the intestine (Schell et al., [@B79]; Ryan et al., [@B75]; Kim et al., [@B44]). Meanwhile, *Lactobacillus* species encode numerous transporters and have a large capacity for sugar internalization and break-down as well as numerous mucus binding cell surface proteins (Kleerebezem et al., [@B48]; Boekhorst et al., [@B7],[@B8]; Siezen et al., [@B85]). *Bifidobacterium* were originally isolated from human baby feces and were identified as a substantial portion of the normal microbiota of humans. Their positive effects were seen through bottle fed babies that lacked *Bifidobacterium* and subsequently suffered from more diarrhea (Kleerebezem and Vaughan, [@B50]). Both *Bifidobacterium* and *Lactobacillus* species are among the first subsets of bacteria to colonize the human colon after birth and decrease in number into adulthood (Favier et al., [@B20]; Vaughan et al., [@B107]). Much of the characterization of *Bifidobacterium* and *Lactobacillus* and their effects on the mammalian host has come through the mono and co-colonization of germ-free mice and observation of immune and physiological responses from the host as well as bacterial transcriptome changes as they adapted to different niches within a host (Sonnenburg et al., [@B88]; Denou et al., [@B16], [@B17]; Menard et al., [@B63]; Kleerebezem and Vaughan, [@B50]) and also through their probiotic effects on humans (Ouwehand, [@B68]; Kleerebezem and Vaughan, [@B50]). Among the many positive effects these groups of bacteria have on hosts is the ability to reduce inflammation. Skewed levels of microbiota are one important factor in inflammatory bowel disease as well as other inflammatory conditions like rheumatoid arthritis (Frank et al., [@B22]; Gueimonde et al., [@B28]; Round and Mazmanian, [@B73]). In mouse models of colitis, under germ-free conditions or after treatment of mice with antibiotics, intestinal inflammation cannot be readily induced (Bamias et al., [@B4]; Strober et al., [@B93]). *Bifidobacterium* and *Lactobacillus* are both important in the natural balance of the intestinal community and in cases of inflammatory bowel disease (IBD), both groups of bacteria are seen at decreased levels in fecal samples as opposed to *Enterococcus* and *Bacteroides*, which are seen elevated in the mucosa of patients (Frank et al., [@B22]). Both *Bifidobacterium lactis* and *Bifidobacterium infantis* have been shown to be protective against inflammation caused by chemically and *Salmonella* induced colitis respectively (Round and Mazmanian, [@B73]). Both species of bacteria can suppress the transcription of the inflammatory factors: IL-1β, tumor necrosis factor (TNF)-α, NFκB and translation of IL-1β and IL-6 (Turpin et al., [@B101]). Treatment of colitic mice with *Bifidobacterium infantis* induces the production of CD4+CD25+ regulatory T-cells and these cells can be adoptively transferred to another mouse and prevent activation of inflammatory factors (O'Mahony et al., [@B67]). Additionally, numerous species of *Lactobacillus* have exerted protective effects against chemically and *IL-10−/−* induced models of colitis (Round and Mazmanian, [@B73]). It has been suggested that *Lactobacillus rhamnosus* can also induce regulatory T-cell activity. Bone marrow dendritic cells (BMDCs) incubated with *Lactobacillus rhamnosus* offer protection from induction of intestinal inflammation in a CD4+CD25+ regulatory T-cells dependent fashion (Foligne et al., [@B21]).

In addition to their anti-inflammatory properties, *Bifidobacterium* and *Lactobacillus* species have been shown to play a role in exclusion of enteric pathogens. For example, the inflammatory effects of disease seen after infection of mice with *Salmonella* serotype Typhimurium can be countered by treating the mice with *Bifidobacterium infantis* through the induction of Foxp3+ T-regulatory cells (O'Mahony et al., [@B67]).

While the precise mechanisms behind the beneficial effects of *Lactobacillus* and *Bifidobacterium* are largely unknown, a significant amount of their activity can be attributed to cell surface associated structures and extracellular protein interaction with mucosal immune cells (Kleerebezem et al., [@B49]). Such cell surface structures include but are not limited to: exopolysaccharides, bacteriocins, lipoteichoic acid, and extracellular proteins (Sanchez et al., [@B77]). Many of these proteins from both *Bifidobacterium* and *Lactobacillus* are primarily identified using bioinformatics and most have yet to be fully characterized. For example, *Lactobacillus plantarum* are capable of adhering to mannosyl moieties on human mucosa and in doing so prevent ETEC infection (Adlerberth et al., [@B1]); however, the responsible mannose specific adhesion (Msa), a sortase dependent cell surface protein was only recently discovered thanks to bioinformatics (Pretzer et al., [@B71]). Informatics searches for potential adhesions, mucin binding domains, and secretory sequences have been very successful (Buck et al., [@B9]; Boekhorst et al., [@B7]; Sanchez et al., [@B76]; Barinov et al., [@B5]). Secreted surface molecules have been shown to play a role in *Bifidobacterium* and *Lactobacillus* CR through the enhancement of the mucosal barrier and tight junctions, induction of anti-microbial peptides, and some secreted proteins are thought to interact directly with host epithelial cells possibly blocking niches for pathogenic bacteria (Sanchez et al., [@B77]). Schlee et al. ([@B80]) showed that numerous species of *Lactobacillus* are able to induce anti-microbial peptide production, which in turn contributes to CR of pathogens. Pre-conditioned media from *Lactobacillus rhamnosus* GG contains peptides with anti-microbial activity against: *E. coli* EAEC, *Salmonella typhi* and *Staphylococcus aereus* (Lu et al., [@B57]). Anti-microbial peptide production by *Lactobacillus salivarius* can protect mice from *Listeria monocytogenes* while non-bacteriocin producing *Lactobacillus* *salivarius* do not confer protection (Corr et al., [@B13]). The *Lactobacillus crispatus* S-layer protein (SlpA) interacts directly with collagen on host epithelial cells (Antikainen et al., [@B2]) and has been shown to block the binding of pathogens such as *Escherichia coli* O157:H7 and *Salmonella typhimurium* (Chen et al., [@B10]), indicating that the CR ability of some probiotics may be directly mediated by adhesion molecules. As well as playing a role in CR, SlpA was shown by Konstantinov et al. to play a role in the induction of host immune responses. They showed that SlpA interacts directly with the non-integrin DC-SIGN, inducing IL-10 production and low IL-12p70 and that in an *slpA* mutant strain, which overexpresses *slpB*, the immune reaction is skewed toward a more pro-inflammatory response (Konstantinov et al., [@B51]). Another extracellular protein immune modulator is the serine protease inhibitor (Serpin) present in many species of *Bifidobacterium*. Ivanov et al. ([@B37]) showed through a series of *in vitro* studies that serpin could inhibit pancreatic neutrophil elastases, thereby modulating host inflammatory responses. *Bifidobacterium* can play a role in mucosal health partially through strengthening of tight junctions. Ewaschuck et al. have shown that *Bifidobacterium infantis* pre-conditioned media (BiCM) can increase production of epithelial cell tight junction proteins and increase transepithelial resistance (TER). This BiCm also had drastic effects *in vivo*, attenuating inflammation and colonic permeability in IL-10 deficient mice in part mediated through the Mapk pathway (Ewaschuk et al., [@B19]). Extracellular proteins secreted by *Lactobacillus* species also play a role in mucosal barrier maintenance through MapKs. Two of the better characterized *Lactobacillus* extracellular proteins are p40 (a hypothetical cell surface antigen) and p75 (a hypothetical cell wall-associated hydrolase). These proteins, when purified, promoted growth in human and murine colonic epithelial cells through activating protein kinase (akt) and were able to reduce TNF-α induced colonic injury in tissue explants (Yan et al., [@B111]; Seth et al., [@B83]).

While many *Lactobacillus* and *Bifidobacterium* species are considered culturable, there are still many uncultured species of each within the intestine indicating that we still have much to discover about *Bifidobacterium* and *Lactobacillus* mechanisms of action and surface molecules (Heilig et al., [@B31]; Ben-Amor et al., [@B6]). Also, while many extracellular and secreted proteins from *Bifidobacterium* and *Lactobacillus* have been characterized *in vitro*, their roles have yet to be confirmed *in vivo* (Kleerebezem et al., [@B49]). Full characterization of secreted and surface proteins from these groups of bacteria could further advance therapeutics in intestinal diseases and our knowledge of immune regulation by commensal bacteria.

Discussion
==========

In this review, we have highlighted several bacterial groups and specific species that have an immunomodulatory impact on their hosts (summarized in Figure [1](#F1){ref-type="fig"}). There are an incredible 10^14^ bacteria in the intestine and the mammalian immune system must be able to sustain these constant visitors without eliciting a strong reaction, yet at the same time, be primed to react to incoming and invading pathogens. We have described several different instances in which intestinal bacteria prime responses that mirror and enhance this vital balance by either promoting inflammatory (SFB and Th17 cells) or anti-inflammatory conditions (*Clostridium, Bacteroides fragilis, Bifidobacterium, and Lactobacillus*).

![**Snapshot of bacterial--host activity in the intestine**. This extremely simplistic view of intestinal activity highlights some of the major roles of different bacteria within the intestine. SFB attach to epithelial cells, induce pro-inflammatory responses, and expand TH17 cells (Davis and Savage, [@B15]; Gaboriau-Routhiau et al., [@B24]; Ivanov and Littman, [@B40]). *Bacteroides fragilis* and many *Clostridium* species induce IL-10 production and the expansion of T-regulatory cells (Mazmanian et al., [@B61],[@B62]; Atarashi et al., [@B3]). In *B. fragilis*, this is mediated through the surface polysaccharide, PSA (Mazmanian et al., [@B62]). Both *Lactobacillus* and *Bifidobacterium* can induce anti-inflammatory cytokine production, anti-microbial peptide, and mucin production, and may adhere to epithelial cells (Adlerberth et al., [@B1]; Pretzer et al., [@B71]; Kleerebezem et al., [@B49]; Sanchez et al., [@B77]; Turpin et al., [@B101]). The secreted proteins, p40 and p75 from many *Lactobacillus* species promote cell growth through a PI-3K and AKT pathway, inhibit apoptosis by causing decreased TNFα levels, and increase transepithelial resistance (TER) through increased tight junction protein production (Yan et al., [@B111]; Seth et al., [@B83]). *Lactobacillus* S-layer protein A (SlpA) binds to DC-SIGN which leads to increased IL-10 production. SlpA can bind directly to epithelial cells, which may play a role in colonization resistance (CR) against pathogenic bacteria (Antikainen et al., [@B2]; Chen et al., [@B10]). The *Bifidobacterium* serine protease inhibitor Serpin inhibits neutrophil elastase, thereby modulating acute inflammation in the intestine (Ivanov et al., [@B37]). Finally, undefined secreted proteins from *Bifidobacterium* species cause an increase in tight junction protein production and thereby TER, contributing to CR (Sanchez et al., [@B77]).](fmicb-02-00148-g001){#F1}

It is interesting that closely related groups of bacteria such as *Clostridium* and SFB can exert such different effects. This is also seen in the case of the pathogen *Clostridium difficile*. These differing effects could possibly be due to uncharacterized effector molecules present on the surface of SFB species versus *Clostridium*. The effects of *B. fragilis* on host immunology are clearly shown to be mediated through the symbiosis factor PSA, which has been well-characterized over the last two decades. Not as much is known about the active molecules from many other symbiotic bacteria. Discovery and characterization of these molecules will be extremely important for fully understanding immune system--bacterial cell interactions. In the case of SFB, the potential molecules that allow its association with epithelial cells and possible effector proteins or carbohydrates that elicit host immune responses from SFB are tantalizing. One of the proposed mechanisms of homeostasis within the intestine that allows residence of bacteria without a hyper-activated immune response is the sequestration of commensal bacteria in the mucus layer of epithelial cells and in the intestinal lumen (Hooper, [@B32]). SFB clearly break this rule. Actin accumulation by eukaryotic epithelial cells has been seen underneath the attachment points (Jepson et al., [@B42]) of SFB to eukaryotic cells. This is highly reminiscent of the manner in which many enteric pathogens such as enterohemorrhagic *E. coli* attach to host cells. These pathogens contain a secretion system that enable them to "inject" effector proteins into host cells (Coburn et al., [@B12]). Is it possible that SFB may have a similar system of their own? This also begs the question as to whether SFB truly are commensal, non-pathogenic organisms. The ability to grow these organisms *in vitro* as well as obtaining the genome sequence of these organisms will allow for studies that will begin to answer these questions.

While we have merely scratched the surface and new roles of different species are continually being discovered, the studies highlighted here give us an idea of how powerful the effects of single bacterial species can be within the intestinal framework. Given an environment of over 500 species, it is remarkable that individual species could have such strong effects. Although mono-colonization of germ-free mice is an excellent way to observe species specific immune modulation, it is also an extremely simplified view of an extremely complex ecosystem and as additional roles of individual species are discovered, investigating how bacteria interact with each other within the intestine will be the next direction. Taken from the simple environment of mono-colonization, it is hard to believe that the roles of bacteria would remain the same once placed in a melting pot of hundreds of species all competing for nutrients and space. However in many cases, such as with *Clostridium, Bifidobacterium*, *Lactobacillus*, SFB, and *Bacteroides*, the effects of these bacteria can be seen when their populations are increased within a conventional animal, not solely within a mono-colonized animal (Dasgupta et al., unpublished data) (Sonnenburg et al., [@B89], [@B88]; Mazmanian et al., [@B61], [@B62]; Stepankova et al., [@B92]; Kleerebezem and Vaughan, [@B50]; Round and Mazmanian, [@B74]). In some cases, such as SFB, immunomodulatory effects are seen more readily in the context of a complete microbiota rather than a mono-colonized animal (Stepankova et al., [@B92]). With such great success at teasing apart the individual contributions of many resident intestinal bacteria through mono-colonization experiments, another body of information will come from determining dynamic interactions between multiple groups of a host's natural inhabitants and trying to determine how they use symbiosis factors to communicate with not only their host tissues, but also each other. Already, many groups have looked at the effects of colonizing mice with a select microbiota that represents many of the abundant species normally present in the mammalian intestine (Hooper et al., [@B34]; Macpherson and Harris, [@B58]; Sonnenburg et al., [@B88]; Round and Mazmanian, [@B73]; Stecher and Hardt, [@B91]).

As described earlier, SFB from a rat cannot attach to the epithelium of mouse and vice versa (Tannock et al., [@B96]; Hooper et al., [@B34]; Macpherson and Harris, [@B58]; Sonnenburg et al., [@B88]). This is one example illustrating that colonization of germ-free animals by any bacteria is not always sufficient to conventionalize the animal. Rather, specific bacterial colonization is necessary. This implies a co-evolutionary relationship between a host and its microbiota. The study of humanized mice (germ-free mice colonized with human fecal samples) is one tool that has been utilized to answer whether hosts require a host-specific microbiota. While humanized mice have a "complete" microbiota, it is foreign. At least two studies have shown that humanized mice may more closely resemble germ-free mice in many immunological traits than conventionalized mice and that colonizing mice with a foreign microbiota cannot completely restore immune defects seen in germ-free mice, nor can it restore many other germ-free defects such as metabolism (Chung et al. submitted; Gaboriau-Routhiau et al., [@B24]). When comparing the composition of microbiota from mice colonized with human fecal matter and mice colonized with mouse cecal matter, the two groups of microbiota had a high degree of resemblance through the genus level. The majority of differences were seen on the species level (Chung et al. submitted) again emphasizing the dramatic effects on the host carried out by individual species.

The interest in the dynamics of microbes in the intestine has existed for decades, but has gained and lost momentum as new technology comes and goes. As we are starting to see definite trends in the composition of the intestine, gain knowledge through sequencing, and identify the diversity of intestinal bacteria through the Microbiome project, we are in a position to understand the gut like we never have before. This knowledge will expand our understanding of bacterial symbiosis factors, host regulation of the commensal microbiota, and likewise bacteria--host communication and bacterial--bacterial communication within the intestine. This will lead to a better understanding of and characterization of intestinal bacterial imbalances that lead to diseased states, giving us a better grasp of this previously mysterious world and the tools to greatly impact intestinal health in the future.
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